Sun Pharmaceuticals Ltd said on Thursday it has received tentative United States Food and Drug Administration's approval for its generic Strattera capsules.
The company has received Abbreviated New Drug Application for the drug, which is used for treatment of attention deficit hyperactivity disorder, it said in a statement to the exchange. The drug is a therapeutic equivalent of Strattera capsules from Eli Lily..
Comments